CHARLES SCHWAB INVESTMENT MANAGEMENT INC - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$156,000
+8.3%
112,888
-5.1%
0.00%
Q4 2021$144,000
-53.8%
118,9780.0%0.00%
Q3 2021$312,000
-50.6%
118,9780.0%0.00%
Q2 2021$631,000
-8.9%
118,978
+15.8%
0.00%
Q1 2021$693,000
+2.7%
102,729
+3.2%
0.00%
Q4 2020$675,000
-9.6%
99,5120.0%0.00%
Q3 2020$747,000
-30.2%
99,512
-2.2%
0.00%
-100.0%
Q2 2020$1,070,000
+116.2%
101,777
+80.8%
0.00%
Q1 2020$495,000
+160.5%
56,303
+9.5%
0.00%
Q4 2019$190,000
-3.1%
51,4050.0%0.00%
Q3 2019$196,000
-40.2%
51,4050.0%0.00%
Q2 2019$328,000
+3.8%
51,405
+34.8%
0.00%
Q1 2019$316,000
+69.0%
38,1340.0%0.00%
Q4 2018$187,000
-19.4%
38,134
+62.5%
0.00%
Q3 2018$232,000
-12.1%
23,464
+22.2%
0.00%
Q2 2018$264,000
-34.7%
19,200
-24.7%
0.00%
Q1 2018$404,000
+59.1%
25,500
+86.1%
0.00%
Q4 2017$254,000
-18.8%
13,7000.0%0.00%
Q3 2017$313,00013,7000.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CAXTON CORP 1,430,021$9,638,0006.26%
RA Capital Management 10,874,613$73,295,0001.10%
Mesirow Financial Investment Management, Inc. 41,961$283,0000.77%
Samsara BioCapital, LLC 601,162$4,052,0000.75%
SILVERARC CAPITAL MANAGEMENT, LLC 102,198$689,0000.38%
Eventide Asset Management 3,450,000$23,253,0000.34%
Orbimed Advisors 5,465,030$36,834,0000.34%
Parkman Healthcare Partners LLC 148,433$1,000,0000.23%
Vivo Capital, LLC 786,883$5,304,0000.19%
Knights of Columbus Asset Advisors LLC 199,954$1,348,0000.13%
View complete list of KALA PHARMACEUTICALS INC shareholders